LY2780301

LY2780301 is an inhibitor of AKT and PI3K used in studies of PI3K-Akt-mTOR Signaling and Apoptosis. In practice, this places the compound in experiments that measure growth-factor signaling, survival control, and nutrient-sensing outputs and caspase-associated cell-death signaling and survival decisions in apoptosis, cancer, and cell signaling models.

By inhibiting AKT and PI3K, LY2780301 can be used to examine growth-factor signaling, survival control, and nutrient-sensing outputs and caspase-associated cell-death signaling and survival decisions. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In apoptosis, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving AKT and PI3K
• Pathway perturbation studies connected to PI3K-Akt-mTOR Signaling and Apoptosis
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, LY2780301 is appropriate when a defined chemical perturbant is needed to connect AKT and PI3K with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in apoptosis, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.